Jayson Bedford
Stock Analyst at Raymond James
(3.86)
# 697
Out of 5,042 analysts
322
Total ratings
56.25%
Success rate
7.39%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $546.51 | +10.34% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $12.89 | +47.40% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $126.85 | +15.10% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $190.40 | +9.77% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $103.03 | +9.68% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $123.48 | +45.77% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $82.74 | +23.28% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $70.33 | +45.03% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $101.11 | +22.64% | 26 | Jul 24, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $320.91 | +12.18% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $147.78 | +25.19% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $185.83 | +45.29% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $18.17 | -28.45% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $12.34 | -18.96% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $131.91 | +105.44% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.83 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $14.95 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $76.10 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.02 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $93.67 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.01 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $73.99 | +16.23% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.65 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.11 | - | 3 | Jan 2, 2018 |
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $546.51
Upside: +10.34%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $12.89
Upside: +47.40%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $126.85
Upside: +15.10%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $190.40
Upside: +9.77%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $103.03
Upside: +9.68%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $123.48
Upside: +45.77%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $82.74
Upside: +23.28%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $70.33
Upside: +45.03%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $101.11
Upside: +22.64%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $320.91
Upside: +12.18%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $147.78
Upside: +25.19%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $185.83
Upside: +45.29%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $18.17
Upside: -28.45%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $12.34
Upside: -18.96%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $131.91
Upside: +105.44%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.83
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $14.95
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $76.10
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $23.02
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $93.67
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.01
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $73.99
Upside: +16.23%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.65
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $16.11
Upside: -